Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Aclaris Therapeutics (ACRS) Return on Assets (2017 - 2025)

Aclaris Therapeutics (ACRS) has 9 years of Return on Assets data on record, last reported at 0.41% in Q4 2025.

  • For Q4 2025, Return on Assets rose 26.0% year-over-year to 0.41%; the TTM value through Dec 2025 reached 0.41%, up 26.0%, while the annual FY2025 figure was 0.36%, 27.0% up from the prior year.
  • Return on Assets reached 0.41% in Q4 2025 per ACRS's latest filing, up from 0.8% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.21% in Q2 2021 and bottomed at 0.8% in Q3 2025.
  • Average Return on Assets over 5 years is 0.42%, with a median of 0.39% recorded in 2024.
  • Peak YoY movement for Return on Assets: grew 29bps in 2024, then plummeted -56bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.35% in 2021, then grew by 1bps to 0.34% in 2022, then tumbled by -33bps to 0.46% in 2023, then tumbled by -46bps to 0.67% in 2024, then skyrocketed by 39bps to 0.41% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.41% in Q4 2025, 0.8% in Q3 2025, and 0.71% in Q2 2025.